Jingjing Guo

Jingjing Guo is an experienced professional in the field of clinical biomarker research and operations management. Currently serving as the Manager of Operations in China for Hematogenix since September 2019, Jingjing Guo leads clinical biomarker central lab services for multiple global clinical trials, oversees biomarker assay transfer and training, and facilitates business development and facility establishment in the Chinese market. Prior to this role, Jingjing Guo held the position of Associate Director of Translational Medicine at 上海观合医药科技有限公司, where responsibilities included leading clinical biomarker research for domestic and global trials and establishing new technology platforms. With previous experience as a scientist at both 葛兰素史克公司 and 上海睿智化学研究有限公司, Jingjing Guo has contributed to numerous projects across various therapeutic areas. Jingjing Guo holds a Ph.D. in Molecular Pharmacology and a Bachelor's degree in Pharmacy from China Pharmaceutical University.